Agribusiness giant Monsanto Co. is challenging a growing trend among dairies to label their milk “hormone free,” saying those claims mislead consumers into believing that the cow growth ...

Monsanto Co. is unloading a harvest of controversy with its $300 million sale of the Posilac cow hormone to drugmaker Eli Lilly & Co.Posilac has never been a big part of St. Louis-based Monsanto ...

Agriculture biotech giant Monsanto Co. said it is planning to sell its business that produces a controversial hormone used to boost milk production in dairy cows. The company said it plans to sell ...

A group of Ontario farmers is claiming victory after Monsanto Co. agreed to sell its Posilac brand of synthetic cow hormones to drug maker Eli Lilly and Co. for $300 million.

Two weeks after Monsanto said it was selling off the business that makes artificial growth hormone for dairy cows, it's found a buyer: Eli Lilly and Co., which has agreed to pay $300 million.

The USDA has washed its hands of GMO regulation, but the SEC is taking a close look at Monsanto's tactics for boosting Roundup sales.

Monsanto has assured the public over and over that its flagship Roundup herbicide doesn’t cause ... but its old-line herbicide business remains quite the cash cow, as its 2014 annual report shows.

St. Louis - Monsanto Company is generating controversy with its $300 million sale of the Posilac cow hormone to drug maker Eli Lilly & Company. The genetically engineered hormone has gotten public ...

Monsanto Co. has agreed to pay the University of California $100 million to settle a patent dispute over a growth hormone used to increase milk production in cows. The agreement, which includes ...

Monsanto, the GM giant, is an unexpected winner in the present BSE crisis currently engulfing the globe. The Europe-wide ban on feeding meat-and-bone meal to animals is leading to a huge increase ...